[Systemic lupus erythematosus: from adolescence to adulthood]

Arch Pediatr. 2010 Jun;17(6):634-5. doi: 10.1016/S0929-693X(10)70034-8.

[Article in French]

Authors

A Mathian¹, Z Amoura

Affiliation

¹ Service de Médecine Interne 2, Centre de Référence National Pour les Lupus et le Syndrome des Antiphospholipides, CHU Pitié-Salpêtrière, AP-HP, Paris, France. alexis.mathian@psl.aphp.fr

PMID: 20654816
DOI: 10.1016/S0929-693X(10)70034-8

No abstract available

MeSH terms

Adolescent
Adrenal Cortex Hormones / therapeutic use
Adult
Combined Modality Therapy
Contraceptives, Oral, Hormonal / therapeutic use
Female
Follow-Up Studies
Forecasting
Humans
Immunosuppressive Agents / therapeutic use
Infant
Infant, Newborn
Infant, Premature, Diseases / diagnosis
Infant, Premature, Diseases / drug therapy
Lupus Erythematosus, Systemic / diagnosis*
Lupus Erythematosus, Systemic / drug therapy
Lupus Erythematosus, Systemic / mortality
Patient Care Team
Pregnancy
Pregnancy Complications / diagnosis
Pregnancy Complications / drug therapy
Survival Rate / trends
Young Adult

Substances

Adrenal Cortex Hormones
Contraceptives, Oral, Hormonal
Immunosuppressive Agents